Stuss, Michal <br/><br/>
Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  May 2013 
 - E1007-11 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2012-3885  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Calcium, Dietary--therapeutic use<br/>Cholecalciferol--therapeutic use<br/>Combined Modality Therapy<br/>Dietary Supplements<br/>Diphosphonates--therapeutic use<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Ibandronic Acid<br/>Leukocytes, Mononuclear--drug effects<br/>Middle Aged<br/>Organometallic Compounds--therapeutic use<br/>Osteoporosis, Postmenopausal--blood<br/>Osteoprotegerin--blood<br/>RANK Ligand--blood<br/>RNA, Messenger--metabolism<br/>Receptor Activator of Nuclear Factor-kappa B--blood<br/>Thiophenes--therapeutic use